Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Greiner

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
British Journal of Haematology|February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximabAnamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Leukemia & Lymphoma|October 6, 2015
Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression statusSamantha Kendrick, Katalin Tus, George Wright, et al.
British Journal of Haematology|March 17, 2010
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphomaAndrea Rinaldi, Daniela Capello, Marta Scandurra, et al.
British Journal of Haematology|March 23, 2011
Integrated profiling of diffuse large B-cell lymphoma with 7q gainEkaterina Chigrinova, Michael Mian, Yulei Shen, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2012
Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular PathologyIris Schrijver, Nazneen Aziz, Daniel H Farkas, et al.
The Journal of Clinical Investigation|December 3, 2011
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisRyan A Hlady, Slavomira Novakova, Jana Opavska, et al.
Blood|September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
The American Journal of Surgical Pathology|July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression ProfilingJi Yuan, George Wright, Andreas Rosenwald, et al.
The American Journal of Surgical Pathology|May 15, 2026
Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP StudyKatrin S Kurz, Sarah L Ondrejka, Brett Collinge, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
British Journal of Haematology|February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximabAnamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Leukemia & Lymphoma|October 6, 2015
Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression statusSamantha Kendrick, Katalin Tus, George Wright, et al.
British Journal of Haematology|March 17, 2010
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphomaAndrea Rinaldi, Daniela Capello, Marta Scandurra, et al.
British Journal of Haematology|March 23, 2011
Integrated profiling of diffuse large B-cell lymphoma with 7q gainEkaterina Chigrinova, Michael Mian, Yulei Shen, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2012
Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular PathologyIris Schrijver, Nazneen Aziz, Daniel H Farkas, et al.
The Journal of Clinical Investigation|December 3, 2011
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisRyan A Hlady, Slavomira Novakova, Jana Opavska, et al.
Blood|September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
The American Journal of Surgical Pathology|July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression ProfilingJi Yuan, George Wright, Andreas Rosenwald, et al.
The American Journal of Surgical Pathology|May 15, 2026
Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP StudyKatrin S Kurz, Sarah L Ondrejka, Brett Collinge, et al.
Pageof 13